塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/02/02 | 6,181 | 6,303 | 6,108 | 6,236 | +8 | +0.1% | 1,789,700 |
2018/02/01 | 6,099 | 6,238 | 6,091 | 6,228 | +191 | +3.2% | 1,345,900 |
2018/01/31 | 6,110 | 6,119 | 6,033 | 6,037 | -103 | -1.7% | 1,713,900 |
2018/01/30 | 6,210 | 6,234 | 6,118 | 6,140 | -77 | -1.2% | 1,227,800 |
2018/01/29 | 6,265 | 6,291 | 6,202 | 6,217 | -45 | -0.7% | 984,800 |
2018/01/26 | 6,253 | 6,307 | 6,242 | 6,262 | +25 | +0.4% | 943,300 |
2018/01/25 | 6,271 | 6,306 | 6,220 | 6,237 | -43 | -0.7% | 797,300 |
2018/01/24 | 6,239 | 6,287 | 6,225 | 6,280 | +18 | +0.3% | 820,000 |
2018/01/23 | 6,218 | 6,309 | 6,209 | 6,262 | +49 | +0.8% | 1,309,900 |
2018/01/22 | 6,147 | 6,220 | 6,129 | 6,213 | +59 | +1% | 1,097,000 |
2018/01/19 | 6,161 | 6,205 | 6,139 | 6,154 | +19 | +0.3% | 890,500 |
2018/01/18 | 6,209 | 6,249 | 6,112 | 6,135 | -32 | -0.5% | 1,715,700 |
2018/01/17 | 6,185 | 6,188 | 6,124 | 6,167 | -42 | -0.7% | 1,359,900 |
2018/01/16 | 6,179 | 6,215 | 6,163 | 6,209 | +37 | +0.6% | 785,300 |
2018/01/15 | 6,143 | 6,185 | 6,115 | 6,172 | +29 | +0.5% | 832,900 |
2018/01/12 | 6,161 | 6,168 | 6,112 | 6,143 | -38 | -0.6% | 1,342,400 |
2018/01/11 | 6,202 | 6,214 | 6,159 | 6,181 | -56 | -0.9% | 961,800 |
2018/01/10 | 6,213 | 6,271 | 6,190 | 6,237 | -133 | -2.1% | 1,607,000 |
2018/01/09 | 6,354 | 6,396 | 6,341 | 6,370 | +46 | +0.7% | 858,700 |
2018/01/05 | 6,286 | 6,325 | 6,259 | 6,324 | +41 | +0.7% | 1,121,800 |
2018/01/04 | 6,188 | 6,286 | 6,154 | 6,283 | +186 | +3.1% | 1,357,100 |
2017/12/29 | 6,116 | 6,127 | 6,082 | 6,097 | -7 | -0.1% | 406,000 |
2017/12/28 | 6,128 | 6,143 | 6,090 | 6,104 | -17 | -0.3% | 499,400 |
2017/12/27 | 6,161 | 6,181 | 6,103 | 6,121 | -66 | -1.1% | 826,300 |
2017/12/26 | 6,206 | 6,229 | 6,181 | 6,187 | -30 | -0.5% | 424,500 |
2017/12/25 | 6,194 | 6,230 | 6,189 | 6,217 | +23 | +0.4% | 228,200 |
2017/12/22 | 6,208 | 6,208 | 6,135 | 6,194 | -26 | -0.4% | 943,000 |
2017/12/21 | 6,280 | 6,287 | 6,196 | 6,220 | -76 | -1.2% | 824,300 |
2017/12/20 | 6,272 | 6,299 | 6,264 | 6,296 | +10 | +0.2% | 641,600 |
2017/12/19 | 6,273 | 6,319 | 6,256 | 6,286 | -23 | -0.4% | 744,200 |
2017/12/18 | 6,218 | 6,319 | 6,213 | 6,309 | +139 | +2.3% | 1,286,500 |
2017/12/15 | 6,195 | 6,219 | 6,130 | 6,170 | -49 | -0.8% | 1,265,000 |
2017/12/14 | 6,230 | 6,266 | 6,202 | 6,219 | +18 | +0.3% | 1,084,300 |
2017/12/13 | 6,190 | 6,236 | 6,172 | 6,201 | +33 | +0.5% | 1,104,300 |
2017/12/12 | 6,182 | 6,204 | 6,134 | 6,168 | -70 | -1.1% | 1,059,800 |
2017/12/11 | 6,213 | 6,239 | 6,171 | 6,238 | +54 | +0.9% | 799,900 |
2017/12/08 | 6,102 | 6,185 | 6,093 | 6,184 | +137 | +2.3% | 2,172,000 |
2017/12/07 | 6,026 | 6,082 | 6,017 | 6,047 | +17 | +0.3% | 1,434,800 |
2017/12/06 | 6,106 | 6,144 | 6,007 | 6,030 | -115 | -1.9% | 1,444,300 |
2017/12/05 | 6,167 | 6,180 | 6,116 | 6,145 | -71 | -1.1% | 983,900 |
2017/12/04 | 6,303 | 6,317 | 6,211 | 6,216 | -122 | -1.9% | 1,249,200 |
2017/12/01 | 6,300 | 6,368 | 6,282 | 6,338 | +79 | +1.3% | 1,528,700 |
2017/11/30 | 6,178 | 6,263 | 6,155 | 6,259 | +102 | +1.7% | 1,559,800 |
2017/11/29 | 6,221 | 6,248 | 6,153 | 6,157 | -26 | -0.4% | 1,331,000 |
2017/11/28 | 6,200 | 6,202 | 6,095 | 6,183 | +128 | +2.1% | 1,360,100 |
2017/11/27 | 6,143 | 6,160 | 6,051 | 6,055 | -122 | -2% | 1,710,500 |
2017/11/24 | 6,178 | 6,195 | 6,143 | 6,177 | -8 | -0.1% | 754,400 |
2017/11/22 | 6,335 | 6,340 | 6,185 | 6,185 | -105 | -1.7% | 1,226,600 |
2017/11/21 | 6,309 | 6,320 | 6,262 | 6,290 | +26 | +0.4% | 838,400 |
2017/11/20 | 6,316 | 6,333 | 6,258 | 6,264 | -141 | -2.2% | 1,077,500 |
1851~
1900
件表示中 / 3774件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 255,900円 | +20.9% | +10.6% | 2.58% | 12.10倍 | 1.60倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 793,400円 | +2.2% | +28.0% | 1.76% | 12.70倍 | 1.54倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 164,300円 | +0.9% | +380.2% | 4.75% | 22.63倍 | 1.95倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 469,900円 | +0.1% | -3.4% | 3.40% | 31.94倍 | 1.58倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 260,500円 | -3.5% | -11.3% | 2.30% | 23.93倍 | 1.62倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム